Views & Reviews Personal View India’s rejection of Novartis’s patent is but a small step in the right direction BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2412 (Published 17 April 2013) Cite this as: BMJ 2013;346:f2412 Article Related content Metrics Responses Peer review Related articles Editor's Choice The Novartis case: weighing innovation against access Published: 08 April 2013; BMJ 346 doi:10.1136/bmj.f2218 Feature Union budget 2013: India “could do better,” say doctors Published: 12 March 2013; BMJ 346 doi:10.1136/bmj.f1605 News Indian Supreme Court rejects Novartis’s appeal on drug patent Published: 02 April 2013; BMJ 346 doi:10.1136/bmj.f2099 Analysis Making medicines evergreen Published: 29 November 2012; BMJ 345 doi:10.1136/bmj.e7941 See more Delhi’s air becomes dangerous to breathe as pollution season takes hold BMJ November 15, 2023, 383 p2688; DOI: https://doi.org/10.1136/bmj.p2688 Nepal’s scramble to piece together a health budget amid rumoured cuts BMJ September 18, 2023, 382 p1824; DOI: https://doi.org/10.1136/bmj.p1824 Doctors in India raise concerns about new mandate to prescribe generically or risk suspension BMJ August 22, 2023, 382 p1930; DOI: https://doi.org/10.1136/bmj.p1930 Cancer: the hospital providing jobs to keep its poverty stricken patients in treatment BMJ July 04, 2023, 382 p1095; DOI: https://doi.org/10.1136/bmj.p1095 Boat clinics of northeast India: bridging health inequities in rural areas BMJ April 26, 2023, 381 p906; DOI: https://doi.org/10.1136/bmj.p906 Cited by... Top drug companies are making drugs more accessible but are also guilty of corruption, report saysFulltext PDF
